Martin J. Duvall
2018
In 2018, Martin J. Duvall earned a total compensation of $2M as Chief Executive Officer at Forte Biosciences, a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $270,932 |
|---|---|
| Option Awards | $1,237,155 |
| Salary | $511,192 |
| Other | $560 |
| Total | $2,019,839 |
Duvall received $1.2M in option awards, accounting for 61% of the total pay in 2018.
Duvall also received $270.9K in non-equity incentive plan, $511.2K in salary and $560 in other compensation.
Rankings
In 2018, Martin J. Duvall's compensation ranked 5,703rd out of 14,244 executives tracked by ExecPay. In other words, Duvall earned more than 60.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,703 out of 14,244 | 60th |
Division Manufacturing | 2,156 out of 5,765 | 63rd |
Major group Chemicals And Allied Products | 798 out of 2,128 | 63rd |
Industry group Drugs | 666 out of 1,817 | 63rd |
Industry Pharmaceutical Preparations | 515 out of 1,391 | 63rd |
Source: SEC filing on April 19, 2019.
Duvall's colleagues
We found three more compensation records of executives who worked with Martin J. Duvall at Forte Biosciences in 2018.